Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

TransMedics Group, Inc. (TMDX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $20.10 Metrics
OS: 32.6 M -8 % ROE
Market cap: $656 M -10 % ROIC
Net cash: $136 M $4.18 per share
EV: $519 M

 
TTM Valuation
EBITDA
EBIT ($10.8) M
EPS ($0.35)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-28-19Dec-29-18Dec-30-17
Revenues162.093.581.730.359.725.814.77.7
            Revenue growth98.2%208.8%37.0% 130.8%76.3%90.7%23.8%
Cost of goods sold0.028.20.09.10.09.77.35.5
Gross profit162.065.381.721.259.716.17.42.1
            Gross margin100.0%69.8%100.0%69.9%100.0%62.3%50.3%27.8%
Selling, general and administrative96.769.960.638.343.023.612.37.6
Research and development     19.913.7 
EBIT-40.9-31.4-48.9-39.4-31.0-29.6-20.2-20.4
            EBIT margin-25.2%-33.6%-59.9%-130.3%-52.0%-114.5%-138.1%-265.8%
Pre-tax income-36.2-36.2-44.2-44.2-28.7-33.5-23.7-20.8
Income taxes0.10.10.00.00.00.00.00.0
            Tax rate        
Net income-36.2-36.2-44.2-44.2-28.7-33.5-23.8-20.8
            Net margin-22.4%-38.8%-54.1%-146.1%-48.2%-129.8%-162.1%-271.0%
 
Diluted EPS($1.23)($1.23)($1.60)($1.60)($1.16)($2.36)($17.48)($4.48)
Shares outstanding (diluted)29.629.627.627.624.714.21.44.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy